Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients

被引:17
|
作者
Veschetti, Laura [1 ]
Sandri, Angela [2 ]
Patuzzo, Cristina [1 ]
Melotti, Paola [3 ]
Malerba, Giovanni [1 ]
Lleo, Maria M. [2 ]
机构
[1] Univ Verona, Dept Neurosci Biomed & Movement Sci, I-37134 Verona, Italy
[2] Univ Verona, Dept Diagnost & Publ Hlth, Microbiol Sect, I-37134 Verona, Italy
[3] Azienda Osped Univ Integrata Verona, Cyst Fibrosis Ctr, I-37126 Verona, Italy
来源
MICROBIAL GENOMICS | 2021年 / 7卷 / 07期
关键词
Achromobacter; cystic fibrosis; lung infection; bacterial evolution; comparative genomics; virulence factors; antibiotic resistance; hypermutation; HYPERMUTABLE PSEUDOMONAS-AERUGINOSA; METALLO-BETA-LACTAMASE; MOLECULAR CHARACTERIZATION; GENETIC ADAPTATION; XYLOSOXIDANS; PREVALENCE; RESISTANCE; DATABASE; STRAINS;
D O I
10.1099/mgen.0.000606
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Achromobacter species are increasingly being detected in cystic fibrosis (CF) patients, where they can establish chronic infections by adapting to the lower airway environment. To better understand the mechanisms contributing to a successful colonization by Achromobacter species, we sequenced the whole genome of 54 isolates from 26 patients with occasional and early/late chronic lung infection. We performed a phylogenetic analysis and compared virulence and resistance genes, genetic variants and mutations, and hypermutability mechanisms between chronic and occasional isolates. We identified five Achromobacter species as well as two non- affiliated genogroups (NGs). Among them were the frequently isolated Achromobacter xylosoxidans and four other species whose clinical importance is not yet clear: Achromobacter insuavis, Achromobacter dolens, Achromobacter insolitus and Achromobacter aegrifaciens. While A. insuavis and A. dolens were isolated only from chronically infected patients and A. aegrifaciens only from occasionally infected patients, the other species were found in both groups. Most of the occasional isolates lacked functional genes involved in invasiveness, chemotaxis, type 3 secretion system and anaerobic growth, whereas the great majority ( 1 year from first colonization) and 78% of late chronic ( 1 year from first colonization) isolates were classified as hypermutators. Although all A. dolens, A. insuavis and NG isolates presented two different mutS genes, these seem to have a complementary rather than compensatory function. In conclusion, our results show that Achromobacter species can exhibit different adaptive mechanisms and some of these mechanisms might be more useful than others in establishing a chronic infection in CF patients, highlighting their importance for the clinical setting and the need for further studies on the less clinically characterized Achromobacter species.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis
    Dalboge, C. S.
    Hansen, C. R.
    Pressler, T.
    Hoiby, N.
    Johansen, H. K.
    JOURNAL OF CYSTIC FIBROSIS, 2011, 10 (05) : 318 - 325
  • [22] Achromobacter xylosoxidans Genomic Characterization and Correlation of Randomly Amplified Polymorphic DNA Profiles of Cystic Fibrosis Patients
    Magni, Annarita
    Trancassini, Maria
    Varesi, Paola
    Iebba, Valerio
    Curci, Anna
    Pecoraro, Claudia
    Cimino, Giuseppe
    Schippa, Serena
    Quattrucci, Serena
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (04) : 1035 - 1039
  • [23] Full characterization of plasmids from Achromobacter ruhlandii isolates recovered from a single patient with cystic fibrosis (CF)
    Steffanowski, Carla
    Papalia, Mariana
    Iriarte, Andres
    Langleib, Mauricio
    Galanternik, Laura
    Gutkind, Gabriel
    Cooper, Vaughn
    Soledad Ramirez, Maria
    Radice, Marcela
    REVISTA ARGENTINA DE MICROBIOLOGIA, 2022, 54 (01): : 3 - 8
  • [24] Structured surveillance of Achromobacter, Pandoraea and Ralstonia species from patients in England with cystic fibrosis
    Coward, Amy
    Kenna, Dervla T. D.
    Woodford, Neil
    Turton, Jane F.
    Armstrong, Malcolm
    Auckland, Cressida
    Bowler, Ian
    Burns, Phillipa
    Cargill, James
    Carroll, Mary
    Flight, William
    Graver, Michelle
    Green, Heather
    Horner, Carolyne
    Jones, Andrew
    Jones, Andrew M.
    Jones, Graeme
    Mayell, Sarah
    Orendi, Jeorge
    Perry, Audrey
    Robb, Ali
    Tucker, Natasha
    Waine, David
    Winstanley, Trevor
    Withers, Nick
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (03) : 388 - 393
  • [25] Effect of respiratory Achromobacter spp. infection on pulmonary function in patients with cystic fibrosis
    Recio, R.
    Branas, P.
    Martinez, M. T.
    Chaves, F.
    Orellana, M. A.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 67 (07) : 952 - 956
  • [26] In Vitro Activity of 22 Antibiotics against Achromobacter Isolates from People with Cystic Fibrosis. Are There New Therapeutic Options?
    Beauruelle, Clemence
    Lamoureux, Claudie
    Mashi, Arsid
    Ramel, Sophie
    Le Bihan, Jean
    Ropars, Thomas
    Dirou, Anne
    Banerjee, Anandadev
    Tande, Didier
    Le Bars, Herve
    Hery-Arnaud, Genevieve
    MICROORGANISMS, 2021, 9 (12)
  • [27] Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients' Lung
    Menetrey, Quentin
    Sorlin, Pauline
    Jumas-Bilak, Estelle
    Chiron, Raphael
    Dupont, Chloe
    Marchandin, Helene
    GENES, 2021, 12 (05)
  • [28] Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
    A. Lambiase
    M. R. Catania
    M. del Pezzo
    F. Rossano
    V. Terlizzi
    A. Sepe
    V. Raia
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30 : 973 - 980
  • [29] Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis
    Evans, Thomas J.
    FUTURE MICROBIOLOGY, 2015, 10 (02) : 231 - 239
  • [30] Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Achromobacter Species from Cystic Fibrosis Patients
    Okoliegbe, Ijeoma N.
    Hijazi, Karolin
    Cooper, Kim
    Ironside, Corinne
    Gould, Ian M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (11)